Shingrix® Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix® Shingrix® safety data – all participants Shingrix® safety data – Aboriginal and Torres Strait Islander participants On 1 November 2023, Shingrix® replaced Zostavax® on the National Immunisation Program schedule for the prevention of shingles and post-herpetic neuralgia. Shingrix® has been available to purchase privately for use in Australia since 2021 and has been shown to be safe and effective both in Australia and overseas. To support the rollout of Shingrix® to a broader population, AusVaxSafety is conducting enhanced active surveillance of Shingrix® across Australia to provide reassurance that the short-term safety profile of the vaccine is consistent with previous surveillance activities.Surveillance data are gathered by AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following Shingrix® vaccination. Data on this page are updated monthly. Latest Shingrix® vaccine safety dataClick on the tiles below to view AusVaxSafety Shingrix® safety data for specific population groups. Shingrix® safety data – all participants View the latest safety data here. Shingrix® safety data – Aboriginal and Torres Strait Islander participants View the latest safety data here. Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix® Shingrix® safety data – all participants Shingrix® safety data – Aboriginal and Torres Strait Islander participants News & events All news & events 02 July 2024 | News Call for participants: new NCIRS study on possible links between genes and adverse events after COVID-19 vaccination 28 March 2024 | News AusVaxSafety commences routine surveillance of 2024 seasonal influenza vaccines 08 March 2024 | News Vaccine safety in Australia AusVaxSafety summary report now available 20 February 2024 | News What to expect in the days after your XBB.1.5 COVID-19 vaccine